TRCT
NVNO

Tower Research Capital (TRC)’s enVVeno Medical NVNO Stock Holding History

Tower Research Capital (TRC)’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.54K Sell
331
-211
-39% -$2.27K ﹤0.01% 4516
2026
Q1 		$5.49K Buy
+542
New +$5.93K ﹤0.01% 4113
2025
Q3 		– Sell
-17
Closed -$2.36K – 5487
2025
Q2 		$2.36K Sell
17
-29
-63% -$3.43K ﹤0.01% 4661
2025
Q1 		$4.22K Sell
46
-147
-76% -$16.4K ﹤0.01% 4286
2024
Q4 		$20.4K Buy
193
+169
+704% +$18.9K ﹤0.01% 3169
2024
Q3 		$2.87K Sell
24
-44
-65% -$8.08K ﹤0.01% 4931
2024
Q2 		$12.5K Sell
68
-32
-32% -$5.59K ﹤0.01% 4024
2024
Q1 		$19K Buy
100
+19
+23% +$3.41K ﹤0.01% 3050
2023
Q4 		$14.6K Buy
81
+80
+8,000% +$12.7K ﹤0.01% 3869
2023
Q3 		$113 Sell
1
-91
-99% -$15.2K ﹤0.01% 5716
2023
Q2 		$9.93K Buy
92
+47
+104% +$6.1K ﹤0.01% 4196
2023
Q1 		$7K Sell
45
-8
-15% -$1.5K ﹤0.01% 4758
2022
Q4 		$9K Sell
53
-23
-30% -$4.67K ﹤0.01% 4226
2022
Q3 		$17K Buy
76
+61
+407% +$13K ﹤0.01% 4077
2022
Q2 		$2K Buy
15
+6
+67% +$931 ﹤0.01% 5575
2022
Q1 		$2K Sell
9
-13
-59% -$2.52K ﹤0.01% 5576
2021
Q4 		$5K Buy
+22
New +$6.2K ﹤0.01% 5174
2021
Q3 		– Sell
-5
Closed -$1K – 6042
2021
Q2 		$1K Sell
5
-12
-71% -$2.58K ﹤0.01% 5226
2021
Q1 		$4K Buy
17
+14
+467% +$3.9K ﹤0.01% 4800
2020
Q4 		$1K Buy
+3
New +$931 ﹤0.01% 5020
2018
Q4 		– Sell
-1
Closed -$2K – 4188
2018
Q3 		$2K Buy
+1
New +$2.31K ﹤0.01% 3456

Other funds holding NVNO

KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
APW
Allied Private Wealth Boca Raton, Florida $156M AUM

Tower Research Capital (TRC)'s NVNO Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its enVVeno Medical (NVNO) stake by 39% in Q2 2026, selling an estimated $2.27K and leaving 331 shares worth $3.54K. The position accounts for ﹤0.01% of the portfolio, ranked #4516.

Tower Research Capital (TRC) first reported a position in NVNO in Q3 2018 and has held it in 21 quarters since. The position peaked at $20.4K in Q4 2024. 17 funds tracked by Wall St. Rank hold NVNO as of Q2 2026.

  • Tower Research Capital (TRC) held 331 shares of enVVeno Medical worth $3.54K as of Q2 2026.
  • Tower Research Capital (TRC) sold 211 enVVeno Medical shares in Q2 2026, an estimated $2.27K.
  • enVVeno Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4516 holding.
  • Tower Research Capital (TRC) first reported a position in enVVeno Medical in Q3 2018 and has held it in 21 quarters since.
  • Tower Research Capital (TRC)'s enVVeno Medical position peaked at $20.4K in Q4 2024.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.